Nanding, Norseda P.

HRN: 26-85-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
AMPICILLIN 1GM (VIAL)
04/10/2025
04/11/2025
IVT
2g
Q6
PROM X 1 Hour
Waiting Final Action 
04/10/2025
CO-AMOXICLAV 625MG (TAB)
04/10/2025
04/16/2025
PO
500mg
BID
Nsvd 3rd Degree
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: